Stock ASPI ASP ISOTOPES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ASP Isotopes Inc.

Equities

ASPI

US00218A1051

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
4.42 USD -3.49% Intraday chart for ASP Isotopes Inc. -13.50% +146.93%
Jun. 03 ASP Isotopes Inc. Receives Purchase Order from a Leading Global Industrial Gases Company for the Supply of Highly Enriched Electronic Gases CI
May. 15 ASP Isotopes Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 54.28 87.3 207.6 - -
Enterprise Value (EV) 1 54.28 87.3 207.6 207.6 207.6
P/E ratio -8.78 x -3.65 x -36.5 x -57.3 x -
Yield - - - - -
Capitalization / Revenue - 202 x 17.8 x 13.2 x 9.3 x
EV / Revenue - 202 x 17.8 x 13.2 x 9.3 x
EV / EBITDA - - - - -
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - - - - -
Nbr of stocks (in thousands) 34,357 48,773 51,763 - -
Reference price 2 1.580 1.790 4.010 4.010 4.010
Announcement Date 3/31/23 4/10/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 0.433 11.65 15.74 22.32
EBITDA - - - - -
EBIT - - - - -
Operating Margin - - - - -
Earnings before Tax (EBT) - - - - -
Net income -4.945 - - - -
Net margin - - - - -
EPS 2 -0.1800 -0.4900 -0.1100 -0.0700 -
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/31/23 4/10/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 3/31/23 4/10/24 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
4.01 USD
Average target price
5.5 USD
Spread / Average Target
+37.16%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ASP ISOTOPES INC. Stock ASP Isotopes Inc.
+146.93% 208M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 765B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 632B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 248B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 219B
NOVARTIS AG Stock Novartis AG
+11.88% 216B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ASPI Stock
  4. Financials ASP Isotopes Inc.